Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Nanoparticle-Based Drug Delivery
TopicLeading institutions, researchers & key papers
This cluster of papers focuses on the development and application of nanoparticle-based drug delivery systems, particularly for cancer therapy. It covers topics such as nanocarriers, surface engineering of nanoparticles, magnetic nanoparticles, tumor targeting, polymeric nanoparticles, and the enhanced permeability and retention (EPR) effect. The research explores the synthesis, functionalization, and biomedical applications of various types of nanoparticles for drug delivery.
228
Works
IDs:OpenAlex
How has Nanoparticle-Based Drug Delivery's publication output changed over time?
ScholarIQpublication output · 2005–2021
Output declined50% over the shown period — from 2 works in 2005 to 1 in 2021.
2
2
1
3
1
1
1
1
1
1
2005200920102011201320152016201820202021
What are the most-cited papers on Nanoparticle-Based Drug Delivery?
ScholarIQmost cited works
Nanomedicine—Challenge and Perspectives
Kristina Riehemann, Stefan W. Schneider, Thomas A. Luger, Biana Godin, Mauro Ferrari, Harald Fuchs
S67393510. 20091,292 CitationsOPEN ACCESS
The Shape Effect of Mesoporous Silica Nanoparticles on Biodistribution, Clearance, and Biocompatibility <i>in Vivo</i>
Xinglu Huang, Linlin Li, Tianlong Liu, Nanjing Hao, Huiyu Liu, Dong Chen, Fangqiong Tang
S145476921. 2011911 Citations
Impact of Silica Nanoparticle Design on Cellular Toxicity and Hemolytic Activity
Yu Tian, Alexander Malugin, Hamidreza Ghandehari
S145476921. 2011659 CitationsOPEN ACCESS
Quantifying the Ligand-Coated Nanoparticle Delivery to Cancer Cells in Solid Tumors
Qin Dai, Stefan Wilhelm, Ding Ding, Abdullah M. Syed, Shrey Sindhwani, Yuwei Zhang, Yih Yang Chen, Presley MacMillan, Warren C. W. Chan
S145476921. 2018653 Citations
Anti-HER2 immunoliposomes: enhanced efficacy attributable to targeted delivery.
John W. Park, Keelung Hong, Dmitri B. Kirpotin, Gail Colbern, Refaat Shalaby, José Baselga, Yvonne Shao, Ulrik B. Nielsen, James D. Marks, Dan H. Moore, Demetrios Papahadjopoulos, Christopher C. Benz
PubMed. 2002648 CitationsOPEN ACCESS
Where is Nanoparticle-Based Drug Delivery research published, and who funds it?
ScholarIQvenues & funding sources
TOP JOURNALS
TOP FUNDERS
National Science Foundation—
NIH—
Wellcome Trust—
European Research Council—
Funder breakdown is a member featureSign up free to unlock
How much of the research on Nanoparticle-Based Drug Delivery is open access?
ScholarIQopen access share
60%OPEN ACCESS
Gold
7%
Green
20%
Hybrid
27%
Bronze
7%
Closed
40%
Related on ScholarIQ
Phase III Trial of Nanoparticle Albumin-Bound Paclitaxel Compared With Polyethylated Castor Oil–Based Paclitaxel in Women With Breast Cancer
Paper
Nanomedicine—Challenge and Perspectives
Paper
The effect of surface charge on in vivo biodistribution of PEG-oligocholic acid based micellar nanoparticles
Paper
A review on phospholipids and their main applications in drug delivery systems
Paper
The Shape Effect of Mesoporous Silica Nanoparticles on Biodistribution, Clearance, and Biocompatibility <i>in Vivo</i>
Paper
Phase I and Pharmacokinetic Study of Genexol-PM, a Cremophor-Free, Polymeric Micelle-Formulated Paclitaxel, in Patients with Advanced Malignancies
Paper